Robin MacGowan
Centers for Disease Control and Prevention
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Robin MacGowan.
International Journal of Std & Aids | 2003
Robin MacGowan; Andrew D. Margolis; Juarlyn Gaiter; Kathleen M. Morrow; Barry Zack; John Askew; Timothy L. McAuliffe; James M. Sosman; Gloria D. Eldridge
A longitudinal study of demographic and behavioural characteristics associated with risky sexual behaviours of young men after release from prison. One hundred and six men were interviewed in prison and at one week and six months after release. Overall, 37% reported a previous sexually transmitted disease (STD) diagnosis. In the 30 days before incarceration, 33% had had sex with a risky partner, and 59% had had multiple female sex partners. After release, 38 (36%) men reported having had risky sex (≥2 female sex partners and unprotected vaginal sex): 12 (13%) at one week and 31 (34%) at six months. The only factor independently associated with risky sex was the use of alcohol/drugs before sex: one-week odds ratio (OR)=6.11 (95% confidence interval [CI]: 1.42-26.40), six-month OR=3.05 (95% CI: 1.30-9.42). Behavioural intervention programmes for incarcerated men should address drug and alcohol use and its contribution to higher risk for HIV and STDs.
Sexually Transmitted Diseases | 2009
Robin MacGowan; Andrew D. Margolis; April Richardson-Moore; Terry Wang; Marlene LaLota; P Tyler French; James Stodola; Jennifer Mckeever; Jack Carrel; Jolene Mullins; Michelle Llanas; Sean David Griffiths
Objectives: To provide human immunodeficiency virus (HIV) rapid testing to persons in jails, identify previously undiagnosed cases of HIV infection, and refer HIV-infected inmates to care, treatment, and prevention services. Design: Four state health departments (Florida, Louisiana, New York, and Wisconsin) collaborated with jails to implement stand-alone voluntary rapid HIV testing programs. Inmates requested or were referred by medical staff for rapid HIV testing. HIV testing was provided by the health department, correctional facility, or a community-based organization. Inmates whose rapid test was reactive were offered confirmatory testing, medical evaluation, prevention services, and discharge planning. Results: From December 2003 through May 2006, rapid HIV testing was provided to 33,211 inmates, more than 99.9% of whom received their test results. Most of the inmates tested were male (79%), black (58%), and less than 35 years of age (60%). A total of 440 (1.3%) rapid HIV tests were reactive, and 409 (1.2%) of the results were confirmed positive. The testing programs identified 269 (0.8%) previously undiagnosed cases of HIV infection. In the multivariate analyses, new HIV diagnoses were associated with race/ethnicity, report of risky behaviors, and with no report of HIV risk behavior. Almost 40% of diagnoses were for inmates whose only reported risk was heterosexual contact. Conclusions: Rapid HIV testing in jails identified a considerable number of previously undiagnosed cases of HIV infection. Rapid HIV testing should be available to all inmates, regardless of whether inmates reported HIV risky behaviors.
Sexually Transmitted Diseases | 2006
Andrew D. Margolis; Robin MacGowan; Olga Grinstead; James M. Sosman; Iqbal Kashif; Timothy P. Flanigan
Objectives: The objectives of this study were to describe preincarceration risk behaviors of young men and identify correlates of unprotected sex with multiple partners during the 3 months before incarceration. Study: Data on preincarceration risk behaviors were obtained from 550 men, aged 18 to 29 years, in state prisons in California, Mississippi, Rhode Island, and Wisconsin. Correlates of unprotected sex with multiple partners were determined by logistic regression. Results: Of 550 participants, 71% had multiple sex partners, 65.1% had sex with a partner they perceived as risky, and 45.3% engaged in unprotected sex with multiple partners. Men who drank heavily (odds ratio [OR], 1.68; 95% confidence interval [CI], 1.11–2.54) or who had a risky partner (OR, 3.90; 95% CI, 2.60–5.85) were more likely to report unprotected sex with multiple partners. Men who attended religious gatherings (OR, 0.66; 95% CI, 0.46–0.96) or lived in stable housing (OR, 0.69; 95% CI, 0.48–1.00) were less likely to report unprotected sex with multiple partners. Conclusions: Most participants engaged in behaviors that could result in a sexually transmitted disease, including HIV. Prevention programs should address the relationship between heavy alcohol use and risky sexual behavior. Discharge planning should address housing needs. Faith-based community organizations may play an important role for some young men in their transition to the community.
Health Psychology | 2000
Dolores Albarracín; Ringo M. Ho; Penny S. McNatt; Wendy R. Williams; Fen Rhodes; C. Kevin Malotte; Tamara Hoxworth; Gail Bolan; Jonathan M. Zenilman; Michael Iatesta; Carolyn Erwin-Johnson; Andrew Lentz; Mary A. Staat; Dawn Sweet; John M. Douglas; Ken Miller; William McGill; Ruth Bundy; Laura A. Hoyt; Eileen Napolitano; Judy Rogers; Ken Spiltany; Colleen Le Drew; Kimberly A.J. Coleman; Luna Hananel; Charlotte K. Kent; Robert Francis; Christopher Gordon; Nancy Rosenshine; Carmita Signes
To study the structure of beliefs about condom use outcomes, the authors derived and tested 4 psychosocial hypothetical models: (a) a 2-factor model of the personal and social outcomes of condom use; (b) a 2-factor model of the pros and cons of the behavior; (c) a 3-factor model (i.e., physical, self-evaluative, and social) of outcome expectancies; and (d) a thematic 4-factor model of the protection, self-concept, pleasure, and interaction implications of the behavior. All 4 models were studied with a confirmatory factor analysis approach in a multisite study of 4,638 participants, and the thematic solution was consistently the most plausible. Self-concept and pleasure were most strongly associated with attitudes toward using condoms, intentions to use condoms, and actual condom use, whereas protection and interaction generally had little influence.
AIDS | 1997
Robin MacGowan; Robert M. Brackbill; Deborah Rugg; Nancy M. Swanson; Beth Weinstein; Alfred Couchon; John Scibak; Susan Molde; Paul McLaughlin; Thomas A. Barker; Rich Voigt
Objectives:To determine whether changes in injecting drug use and sexual behavior over a 12-month follow-up are associated with HIV counseling and testing (C and T) of injecting drug users in methadone maintenance treatment programs (MMTP) in Massachusetts and Connecticut. Methods:Clients were invited to participate in a longitudinal study involving five interviews. Data were also obtained by ethnographers and from clinical records. Behavioral outcomes of interest were number of drug injections, sharing of unclean ‘works’ (injecting equipment), number of unprotected sex partners, and number of unprotected sexual episodes. Data analyses included multiple regression, odds ratios, and quantitative analysis of text-based data. Results:Subjects reported reductions in both injecting drug use and sexual behavior. Primary associations with reduced injecting drug use were remaining in the MMTP and attending HIV-positive support groups. A reduction in high-risk sexual behavior was associated with an HIV-positive test result and duration of HIV counseling in the MMTP. Increase in drug injecting use was associated with an HIV-positive test result. Inconsistent condom use was associated with enrollment in the MMTP where condoms were available only upon request and abstinence and monogamy between uninfected partners were promoted. Conclusions:Injecting drug users who self-select to participate in MMTP and HIV C and T, two public health HIV-prevention interventions, reduce their HIV-risk behaviors. Clients should be encouraged to remain in MMTP and HIV-infected clients should attend support groups for HIV-positive persons. MMTP staff should promote a variety of safer sex behaviors and provide condoms without request.
Journal of Psychoactive Drugs | 1996
Robin MacGowan; Nancy M. Swanson; Robert M. Brackbill; Deborah Rugg; Thomas A. Barker; Susan Molde
The goal of this study was to identify factors associated with six- and 12-month retention in methadone maintenance treatment programs (MMTPs) in Massachusetts and Connecticut. Data was obtained from 674 participants, clinic records, and clinic staff. Ethnographic and logistic regression analyses were conducted. Overall, 69% and 48% of the clients remained in treatment at six months and 12 months, respectively. The MMTPs were categorized as either a 12-Step, case management, or primary care model. Factors independently associated with retention in treatment at six months were each one-year increase in age of client (OR 1.05), injecting at three months (OR 0.47), and enrollment in the primary care model (OR 2.10). The same factors were associated with 12-month retention in treatment. To retain clients in MMTPs-which should, in turn, help reduce drug use and prevent HIV transmission among IDUs-younger IDUs and clients still injecting at three months after entering drug treatment may need additional services from the staff, or alternative treatment regimens. MMTP directors should consider differences between these programs and, if appropriate, make changes to increase retention in treatment.
Sexually Transmitted Diseases | 2009
Ram K. Shrestha; Stephanie L. Sansom; April Richardson-Moore; P Tyler French; Beth Scalco; Marlene LaLota; Michelle Llanas; James Stodola; Robin MacGowan; Andrew D. Margolis
Objective: To assess the costs of rapid human immunodeficiency virus (HIV) testing and counseling to identify new diagnoses of HIV infection among jail inmates. Study Design: We obtained program costs and testing outcomes from rapid HIV testing and counseling services provided in jails from March 1, 2004, through February 28, 2005, in Florida, Louisiana, New York, and Wisconsin. We obtained annual program delivery costs—fixed and variable costs—from each project area. We estimated the average cost of providing counseling and testing to HIV-negative and HIV-infected inmates and estimated the cost per newly diagnosed HIV infection. Results: In the 4 project areas, 17,433 inmates (range, 2185–6463) were tested: HIV infection was diagnosed for 152 inmates (range, 4–81). The average cost of testing ranged from
Evaluation & the Health Professions | 2000
Judith Greenberg; Michael Hennessy; Robin MacGowan; David D. Celentano; Virginia Gonzales; Nancy Van Devanter; Julie Lifshay
29.46 to
International Journal of Std & Aids | 2005
James M. Sosman; Robin MacGowan; Andrew D. Margolis; Gloria D. Eldridge; Timothy P. Flanigan; J Vardaman; C Fitzgerald; Deborah Kacanek; Diane Binson; David W. Seal; Charlotte A. Gaydos
44.98 for an HIV-negative inmate and from
Mayo Clinic Proceedings | 2012
Stacey A. Rizza; Robin MacGowan; David W. Purcell; Bernard M. Branson; Zelalem Temesgen
71.37 to